CSL Vifor Overview

  • Year Founded
  • 1871

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2,600

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 7

  • Investments
  • 32

CSL Vifor General Information

Description

Operator of a specialty drug manufacturing and licensing company focused on iron deficiency and kidney diseases. The company specializes in global strategic collaboration, licensing, and the development, manufacturing, and commercialization of precision healthcare pharmaceuticals to help patients worldwide lead better, healthier lives.

Contact Information

Website
www.cslvifor.es
Formerly Known As
Galenica Ag
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Flughofstrasse 61
  • P.O. Box
  • 8152 Glattbrugg
  • Switzerland
+41 058
Primary Industry
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • Flughofstrasse 61
  • P.O. Box
  • 8152 Glattbrugg
  • Switzerland
+41 058

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CSL Vifor Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CSL Vifor‘s full profile, request access.

Request a free trial

CSL Vifor Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a specialty drug manufacturing and licensing company focused on iron deficiency and kidney diseases. The com
Pharmaceuticals
Glattbrugg, Switzerland
2,600 As of 2024

Mumbai, India
 

Ahmedabad, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CSL Vifor Competitors (32)

One of CSL Vifor’s 32 competitors is Sun Pharmaceutical Industries, a Corporation company based in Mumbai, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sun Pharmaceutical Industries Corporation Mumbai, India
Zydus Lifesciences Corporation Ahmedabad, India
Dr. Reddy's Corporation Hyderabad, India
Cipla Corporation Mumbai, India
GSK Corporation London, United Kingdom
You’re viewing 5 of 32 competitors. Get the full list »

CSL Vifor Patents

CSL Vifor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026120158-A1 Process for reducing no-impurities (ndsris) in solid dosage forms of ferroportin inhibitors Pending 06-Dec-2024
WO-2026120150-A1 Prolonged-release dosage forms of ferroportin inhibitors Pending 06-Dec-2024
WO-2026120152-A1 Prolonged-release dosage forms of ferroportin inhibitors for use in treating hereditary haemochromatosis Pending 06-Dec-2024
WO-2026041650-A1 Ferroportin-inhibitors for the use in the treatment of lupus nephritis Pending 20-Aug-2024
EP-4828610-A1 Novel synthesis of methyl-2-fluoroacrylate Pending 21-Dec-2023 C07C67/08
To view CSL Vifor’s complete patent history, request access »

CSL Vifor Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CSL Vifor Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CSL Vifor‘s full profile, request access.

Request a free trial

CSL Vifor Investments & Acquisitions (32)

CSL Vifor’s most recent deal was a Merger/Acquisition with Inositec for . The deal was made on 30-Nov-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Inositec 30-Nov-2021 Merger/Acquisition Drug Discovery
Sanifit 22-Nov-2021 Merger/Acquisition Drug Discovery
Angion Biomedica 09-Feb-2021 PIPE Drug Discovery
Cara Therapeutics 15-Oct-2020 PIPE Drug Discovery
Weifu Fresenius Kabi 29-May-2020 Joint Venture Consulting Services (B2B)
You’re viewing 5 of 32 investments and acquisitions. Get the full list »

CSL Vifor Exits (7)

CSL Vifor’s most recent exit was on 15-Oct-2020 from Cara Therapeutics. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Cara Therapeutics 15-Oct-2020 Completed
NephThera 06-Nov-2019 Completed
  • 2 buyers
Akebia Therapeutics 15-May-2017 Completed
Chemocentryx 11-May-2016 Completed
OM Pharma 08-Sep-2009 Merger/Acquisition Completed
You’re viewing 5 of 7 exits. Get the full list »

CSL Vifor Affiliates

Subsidiaries (5)

Name Industry Location Year Founded
Renapharma Stockholm, Sweden 2000
Sun Store Bern, Switzerland 1972
Perskindol Switzerland 1954
Galenica Personalvorsorgestiftung Bern, Switzerland 1940
Galexis Niederbipp, Switzerland

CSL Vifor FAQs

  • When was CSL Vifor founded?

    CSL Vifor was founded in 1871.

  • Where is CSL Vifor headquartered?

    CSL Vifor is headquartered in Glattbrugg, Switzerland.

  • What is the size of CSL Vifor?

    CSL Vifor has 2,600 total employees.

  • What industry is CSL Vifor in?

    CSL Vifor’s primary industry is Pharmaceuticals.

  • Is CSL Vifor a private or public company?

    CSL Vifor is a Private company.

  • What is the current valuation of CSL Vifor?

    The current valuation of CSL Vifor is .

  • What is CSL Vifor’s current revenue?

    The current revenue for CSL Vifor is .

  • How much funding has CSL Vifor raised over time?

    CSL Vifor has raised $103M.

  • Who are CSL Vifor’s investors?

    Alliance Healthcare, Ally Bridge Group, Kohlberg Kravis Roberts, and Priora have invested in CSL Vifor.

  • Who are CSL Vifor’s competitors?

    Sun Pharmaceutical Industries, Zydus Lifesciences, Dr. Reddy's, Cipla, and GSK are some of the 32 competitors of CSL Vifor.

  • When was CSL Vifor acquired?

    CSL Vifor was acquired on 09-Aug-2022.

  • Who acquired CSL Vifor?

    CSL Vifor was acquired by CSL.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process